nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—Cyclopentolate—BCHE—peripheral nervous system neoplasm	0.00603	0.724	CrCbGaD
Hyoscyamine—Scopolamine—ABCB1—peripheral nervous system neoplasm	0.00229	0.276	CrCbGaD
Hyoscyamine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.0008	0.000806	CcSEcCtD
Hyoscyamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000798	0.000805	CcSEcCtD
Hyoscyamine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000796	0.000803	CcSEcCtD
Hyoscyamine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000793	0.0008	CcSEcCtD
Hyoscyamine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000793	0.0008	CcSEcCtD
Hyoscyamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000791	0.000798	CcSEcCtD
Hyoscyamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000791	0.000798	CcSEcCtD
Hyoscyamine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000789	0.000796	CcSEcCtD
Hyoscyamine—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000784	0.00079	CcSEcCtD
Hyoscyamine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000782	0.000788	CcSEcCtD
Hyoscyamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000781	0.000788	CcSEcCtD
Hyoscyamine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.00078	0.000787	CcSEcCtD
Hyoscyamine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000779	0.000786	CcSEcCtD
Hyoscyamine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000779	0.000786	CcSEcCtD
Hyoscyamine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000776	0.000783	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000773	0.00078	CcSEcCtD
Hyoscyamine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000772	0.000778	CcSEcCtD
Hyoscyamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000771	0.000778	CcSEcCtD
Hyoscyamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000765	0.000771	CcSEcCtD
Hyoscyamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000765	0.000771	CcSEcCtD
Hyoscyamine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000764	0.00077	CcSEcCtD
Hyoscyamine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000756	0.000762	CcSEcCtD
Hyoscyamine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000753	0.00076	CcSEcCtD
Hyoscyamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.000756	CcSEcCtD
Hyoscyamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00075	0.000756	CcSEcCtD
Hyoscyamine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000747	0.000754	CcSEcCtD
Hyoscyamine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000747	0.000754	CcSEcCtD
Hyoscyamine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000747	0.000753	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000747	0.000753	CcSEcCtD
Hyoscyamine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000742	0.000748	CcSEcCtD
Hyoscyamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000741	0.000748	CcSEcCtD
Hyoscyamine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.000746	CcSEcCtD
Hyoscyamine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000737	0.000743	CcSEcCtD
Hyoscyamine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000737	0.000743	CcSEcCtD
Hyoscyamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000735	0.000742	CcSEcCtD
Hyoscyamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000735	0.000742	CcSEcCtD
Hyoscyamine—Rash—Topotecan—peripheral nervous system neoplasm	0.000735	0.000741	CcSEcCtD
Hyoscyamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000735	0.000741	CcSEcCtD
Hyoscyamine—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000734	0.00074	CcSEcCtD
Hyoscyamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000731	0.000737	CcSEcCtD
Hyoscyamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000729	0.000735	CcSEcCtD
Hyoscyamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000729	0.000735	CcSEcCtD
Hyoscyamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000729	0.000735	CcSEcCtD
Hyoscyamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000729	0.000735	CcSEcCtD
Hyoscyamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000729	0.000735	CcSEcCtD
Hyoscyamine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000728	0.000734	CcSEcCtD
Hyoscyamine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000726	0.000733	CcSEcCtD
Hyoscyamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000726	0.000732	CcSEcCtD
Hyoscyamine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000726	0.000732	CcSEcCtD
Hyoscyamine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000725	0.000731	CcSEcCtD
Hyoscyamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000725	0.000731	CcSEcCtD
Hyoscyamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000725	0.000731	CcSEcCtD
Hyoscyamine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000722	0.000728	CcSEcCtD
Hyoscyamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000722	0.000728	CcSEcCtD
Hyoscyamine—Pain—Vincristine—peripheral nervous system neoplasm	0.000722	0.000728	CcSEcCtD
Hyoscyamine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.000728	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000722	0.000728	CcSEcCtD
Hyoscyamine—Rash—Melphalan—peripheral nervous system neoplasm	0.00072	0.000726	CcSEcCtD
Hyoscyamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000719	0.000725	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000717	0.000723	CcSEcCtD
Hyoscyamine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000721	CcSEcCtD
Hyoscyamine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000714	0.00072	CcSEcCtD
Hyoscyamine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00071	0.000716	CcSEcCtD
Hyoscyamine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000698	0.000704	CcSEcCtD
Hyoscyamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000697	0.000702	CcSEcCtD
Hyoscyamine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000696	0.000702	CcSEcCtD
Hyoscyamine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000693	0.000699	CcSEcCtD
Hyoscyamine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000693	0.000699	CcSEcCtD
Hyoscyamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000693	0.000698	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000691	0.000697	CcSEcCtD
Hyoscyamine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00069	0.000696	CcSEcCtD
Hyoscyamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000687	0.000693	CcSEcCtD
Hyoscyamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000687	0.000693	CcSEcCtD
Hyoscyamine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.000692	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000684	0.00069	CcSEcCtD
Hyoscyamine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000685	CcSEcCtD
Hyoscyamine—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000685	CcSEcCtD
Hyoscyamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000678	0.000684	CcSEcCtD
Hyoscyamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000678	0.000684	CcSEcCtD
Hyoscyamine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000675	0.00068	CcSEcCtD
Hyoscyamine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000672	0.000677	CcSEcCtD
Hyoscyamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000668	0.000673	CcSEcCtD
Hyoscyamine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000668	0.000673	CcSEcCtD
Hyoscyamine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000668	0.000673	CcSEcCtD
Hyoscyamine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000666	0.000672	CcSEcCtD
Hyoscyamine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000662	0.000667	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000662	0.000667	CcSEcCtD
Hyoscyamine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.000663	CcSEcCtD
Hyoscyamine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000657	0.000663	CcSEcCtD
Hyoscyamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000647	0.000652	CcSEcCtD
Hyoscyamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000646	0.000651	CcSEcCtD
Hyoscyamine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000639	0.000645	CcSEcCtD
Hyoscyamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000639	0.000644	CcSEcCtD
Hyoscyamine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000631	0.000636	CcSEcCtD
Hyoscyamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000629	0.000634	CcSEcCtD
Hyoscyamine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000634	CcSEcCtD
Hyoscyamine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000624	0.000629	CcSEcCtD
Hyoscyamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000622	0.000628	CcSEcCtD
Hyoscyamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00062	0.000625	CcSEcCtD
Hyoscyamine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000616	0.000621	CcSEcCtD
Hyoscyamine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00061	0.000615	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000608	0.000614	CcSEcCtD
Hyoscyamine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000608	0.000613	CcSEcCtD
Hyoscyamine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000613	CcSEcCtD
Hyoscyamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000606	0.000611	CcSEcCtD
Hyoscyamine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000601	0.000606	CcSEcCtD
Hyoscyamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000601	0.000606	CcSEcCtD
Hyoscyamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0006	0.000605	CcSEcCtD
Hyoscyamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000596	0.000601	CcSEcCtD
Hyoscyamine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00059	0.000595	CcSEcCtD
Hyoscyamine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00059	0.000595	CcSEcCtD
Hyoscyamine—Pain—Etoposide—peripheral nervous system neoplasm	0.000585	0.00059	CcSEcCtD
Hyoscyamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000585	0.00059	CcSEcCtD
Hyoscyamine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00059	CcSEcCtD
Hyoscyamine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000584	0.000589	CcSEcCtD
Hyoscyamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00058	0.000585	CcSEcCtD
Hyoscyamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000578	0.000583	CcSEcCtD
Hyoscyamine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000581	CcSEcCtD
Hyoscyamine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000564	0.000569	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000568	CcSEcCtD
Hyoscyamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000562	0.000566	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00056	0.000564	CcSEcCtD
Hyoscyamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000559	0.000563	CcSEcCtD
Hyoscyamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000557	0.000562	CcSEcCtD
Hyoscyamine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000561	CcSEcCtD
Hyoscyamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.000557	CcSEcCtD
Hyoscyamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000552	0.000557	CcSEcCtD
Hyoscyamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00055	0.000555	CcSEcCtD
Hyoscyamine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00055	0.000554	CcSEcCtD
Hyoscyamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000549	0.000554	CcSEcCtD
Hyoscyamine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000544	0.000548	CcSEcCtD
Hyoscyamine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000541	0.000545	CcSEcCtD
Hyoscyamine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000541	0.000545	CcSEcCtD
Hyoscyamine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000541	0.000545	CcSEcCtD
Hyoscyamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000537	0.000542	CcSEcCtD
Hyoscyamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000536	0.00054	CcSEcCtD
Hyoscyamine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000533	0.000538	CcSEcCtD
Hyoscyamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000533	0.000537	CcSEcCtD
Hyoscyamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000532	0.000537	CcSEcCtD
Hyoscyamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000529	0.000534	CcSEcCtD
Hyoscyamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000521	0.000525	CcSEcCtD
Hyoscyamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000511	0.000515	CcSEcCtD
Hyoscyamine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000513	CcSEcCtD
Hyoscyamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000504	0.000508	CcSEcCtD
Hyoscyamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000502	0.000506	CcSEcCtD
Hyoscyamine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000505	CcSEcCtD
Hyoscyamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000491	0.000495	CcSEcCtD
Hyoscyamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000484	0.000488	CcSEcCtD
Hyoscyamine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000486	CcSEcCtD
Hyoscyamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000475	0.000479	CcSEcCtD
Hyoscyamine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000477	CcSEcCtD
Hyoscyamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000471	0.000475	CcSEcCtD
Hyoscyamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000471	0.000474	CcSEcCtD
Hyoscyamine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00047	0.000474	CcSEcCtD
Hyoscyamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000468	0.000472	CcSEcCtD
Hyoscyamine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000468	CcSEcCtD
Hyoscyamine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000461	0.000465	CcSEcCtD
Hyoscyamine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00046	0.000464	CcSEcCtD
Hyoscyamine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000456	0.00046	CcSEcCtD
Hyoscyamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000453	0.000456	CcSEcCtD
Hyoscyamine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.00045	CcSEcCtD
Hyoscyamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000444	0.000447	CcSEcCtD
Hyoscyamine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000443	0.000447	CcSEcCtD
Hyoscyamine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000441	CcSEcCtD
Hyoscyamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000435	0.000439	CcSEcCtD
Hyoscyamine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000439	CcSEcCtD
Hyoscyamine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000436	CcSEcCtD
Hyoscyamine—Rash—Etoposide—peripheral nervous system neoplasm	0.000431	0.000435	CcSEcCtD
Hyoscyamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000431	0.000435	CcSEcCtD
Hyoscyamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000429	0.000432	CcSEcCtD
Hyoscyamine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000427	0.00043	CcSEcCtD
Hyoscyamine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000429	CcSEcCtD
Hyoscyamine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000426	CcSEcCtD
Hyoscyamine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000426	CcSEcCtD
Hyoscyamine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000425	CcSEcCtD
Hyoscyamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000419	CcSEcCtD
Hyoscyamine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000417	CcSEcCtD
Hyoscyamine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00041	0.000413	CcSEcCtD
Hyoscyamine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000411	CcSEcCtD
Hyoscyamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000406	0.00041	CcSEcCtD
Hyoscyamine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.0004	0.000403	CcSEcCtD
Hyoscyamine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.000403	CcSEcCtD
Hyoscyamine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000402	CcSEcCtD
Hyoscyamine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000395	CcSEcCtD
Hyoscyamine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000394	CcSEcCtD
Hyoscyamine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000393	CcSEcCtD
Hyoscyamine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000387	0.00039	CcSEcCtD
Hyoscyamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000388	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000387	CcSEcCtD
Hyoscyamine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000387	CcSEcCtD
Hyoscyamine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000385	CcSEcCtD
Hyoscyamine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000381	CcSEcCtD
Hyoscyamine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.00038	CcSEcCtD
Hyoscyamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000378	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000374	CcSEcCtD
Hyoscyamine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000373	CcSEcCtD
Hyoscyamine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000372	CcSEcCtD
Hyoscyamine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000365	CcSEcCtD
Hyoscyamine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000361	CcSEcCtD
Hyoscyamine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000361	CcSEcCtD
Hyoscyamine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000358	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000358	CcSEcCtD
Hyoscyamine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000352	CcSEcCtD
Hyoscyamine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000347	0.00035	CcSEcCtD
Hyoscyamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000349	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000346	CcSEcCtD
Hyoscyamine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000345	CcSEcCtD
Hyoscyamine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000344	CcSEcCtD
Hyoscyamine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000338	0.00034	CcSEcCtD
Hyoscyamine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000334	CcSEcCtD
Hyoscyamine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000333	CcSEcCtD
Hyoscyamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000331	CcSEcCtD
Hyoscyamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000331	CcSEcCtD
Hyoscyamine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000324	CcSEcCtD
Hyoscyamine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000319	CcSEcCtD
Hyoscyamine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000319	CcSEcCtD
Hyoscyamine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000318	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000316	CcSEcCtD
Hyoscyamine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000315	CcSEcCtD
Hyoscyamine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000309	CcSEcCtD
Hyoscyamine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000307	CcSEcCtD
Hyoscyamine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000306	CcSEcCtD
Hyoscyamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000306	CcSEcCtD
Hyoscyamine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000306	CcSEcCtD
Hyoscyamine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000306	CcSEcCtD
Hyoscyamine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000295	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00029	0.000293	CcSEcCtD
Hyoscyamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000285	CcSEcCtD
Hyoscyamine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000284	CcSEcCtD
Hyoscyamine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000283	CcSEcCtD
Hyoscyamine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000283	CcSEcCtD
Hyoscyamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000278	CcSEcCtD
Hyoscyamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000274	CcSEcCtD
Hyoscyamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000265	CcSEcCtD
Hyoscyamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000264	CcSEcCtD
Hyoscyamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000257	CcSEcCtD
Hyoscyamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000256	CcSEcCtD
Hyoscyamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000253	CcSEcCtD
Hyoscyamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000246	CcSEcCtD
Hyoscyamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000245	CcSEcCtD
Hyoscyamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000244	CcSEcCtD
Hyoscyamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000244	CcSEcCtD
Hyoscyamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.00024	0.000242	CcSEcCtD
Hyoscyamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000237	CcSEcCtD
Hyoscyamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000228	0.00023	CcSEcCtD
Hyoscyamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000228	CcSEcCtD
Hyoscyamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000226	CcSEcCtD
Hyoscyamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000225	CcSEcCtD
Hyoscyamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000224	CcSEcCtD
Hyoscyamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000213	CcSEcCtD
